News Daily News CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself Todd Neale June 10, 2021
News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021
News Conference News ACC 2021 High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE Michael O'Riordan May 15, 2021
News Conference News SCAI 2021 ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later Michael O'Riordan May 06, 2021
News Daily News VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms Todd Neale May 06, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Daily News Highest-Risk Patients Gain the Most From Intensive BP Therapy Todd Neale April 20, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News INSPIRATION: No Dip in COVID-19 Deaths or Thromboses With Higher Anticoagulation Dose L.A. McKeown March 19, 2021
News Daily News Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD Michael O'Riordan February 19, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021
News Daily News CAC Screening Cost-effective for Statin Decisions in Hereditary CAD Michael O'Riordan January 14, 2021
News Daily News Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests Michael O'Riordan January 05, 2021
News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020